SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tuck3/28/2018 9:43:27 AM
1 Recommendation

Recommended By
scaram(o)uche

   of 3661
 
Edge Therapeutics (EDGE) off 88% as I type on P3 whiff in subarachnoid hemorrhage via DMC saying low odds of success. The drop is so severe because the company doesn't really have anything else. And this is doubly weirding out investors, since the trial got a go signal on futility a couple of months ago, which helped propel the stock some. Didn't own any, thankfully, but that's two clinical strikes against my charity portfolio, so it still sucks a little bit for me. More for the target population. Might be worth a trading bounce for experts at such things, but otherwise, I see no reason to bottom fish this.


Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News